TABLE 1.
Demographics of 63 patients with 68 malignant hepatic tumors
| Characteristic | CN group | V group | CN and V groups |
|---|---|---|---|
| Age (y), median (range) | 64.94 (27–88) | 59.67 (45–75) | 63.94 (27–88) |
| Sex, M:F | 24:27 | 7:5 | 31:32 |
| Tumor size (cm), mean (range) | 2.5 (.6–5.0) | 3.4 (2.0–5.0) | 2.7 (.6–5.0) |
| Tumor type | |||
| HCC | 17 | 2 | 19 |
| Colorectal cancer | 20 | 9 | 29 |
| Breast cancer | 7 | 0 | 7 |
| Cholangiocarcinoma | 3 | 0 | 3 |
| Lung cancer | 2 | 0 | 2 |
| Neuroendocrine cancer | 2 | 0 | 2 |
| Ovarian cancer | 1 | 0 | 1 |
| Retroperitoneal cancer | 1 | 0 | 1 |
| Duodenal cancer | 1 | 0 | 1 |
| Round cell tumor | 1 | 0 | 1 |
| Leiomyosarcoma | 0 | 2 | 2 |
| Adjuvant chemotherapy | 22 | 8 | 30 |
| Prior hepatic surgery | 16 | 7 | 23 |
| Total no. of lesions | 55 | 13 | 68 |
| Extrahepatic disease (n = 18)a | |||
| Lung | 6 | 5 | – |
| Lymph node | 4 | 4 | – |
| Bone | 3 | 2 | – |
| Peritoneum | 1 | 0 | – |
| Total | 10/51 (20 %) | 8/12 (67 %) | 18/63 (29 %) |
| No. of patients with disease at two sites | 4/51 (8 %) | 3/12 (25 %) | 7/63 (11 %) |
a
Seven patients had two sites